文献速递儿科与产科急症重症综合管理与镇静镇痛

右美托咪定联合氯胺酮用于儿科程序性镇静或术前用药的Meta分析

Dexmedetomidine in combination with ketamine for pediatric procedural sedation or premedication: A meta-analysis.
PubMed 文献 · Am J Emerg Med · 2021-08-31
一句话结论DEX-KET用于儿科镇静比单用DEX或KET起效更快、苏醒更短,血流动力学和呼吸稳定,不良事件发生率低。

该Meta分析纳入15项研究共1087例儿科患者,评估右美托咪定联合氯胺酮(DEX-KET)用于程序性镇静或术前用药的有效性。结果显示DEX-KET的镇静起效时间显著短于DEX组;DEX-KET组心率从开始到镇静结束下降(-3.5至-8.7 BPM),平均动脉压无变化;DEX组心率下降更明显(-11.6 BPM)且平均动脉压下降;DEX-KET低血压发生率3%,心动过缓2%,氧饱和度下降3%,均低于或与对照相当。结论认为DEX-KET镇静效果优于单用DEX或KET,血流动力学和呼吸稳定,不良事件少。

要点

  • DEX-KET用于儿科程序性镇静或术前用药时,镇静起效时间显著短于单用DEX。
  • DEX-KET组心率下降幅度小于DEX组(-8.7 vs -11.6 BPM),且平均动脉压无变化。
  • DEX-KET组低血压发生率3%,心动过缓2%,氧饱和度下降3%,不良事件发生率低。
  • 单用DEX与较高的心动过缓发生率相关(12%),单用KET和PROP-KET与较高的氧饱和度下降发生率相关(12%和13%)。
  • MIDA-KET组心动过速发生率为13%。

适用人群与场景

  • 接受程序性镇静或术前用药的儿科患者(基于纳入的15项研究,共1087例)。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及具体药物剂量、给药途径、频次或目标值。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:Meta分析,纳入15项研究,共1087例儿科患者。
  • 干预与对照:比较DEX-KET与对照(DEX、KET、PROP-KET、MIDA-KET等)的镇静起效和恢复时间、心率、呼吸频率、氧饱和度和平均动脉压变化,以及不良事件发生率。
  • 主要终点结果:DEX-KET镇静起效时间显著短于DEX组;DEX-KET组心率从开始(-3.5 BPM [95%CI: -5.1, -1.9])到中点(-7.2 BPM [95%CI: -12.1, -2.3])和结束(-8.7 BPM [95%CI: -13.1, -4.4])下降;DEX组心率下降-11.6 BPM [95%CI: -16.0, -7.1];DEX-KET组平均动脉压无变化,DEX组平均动脉压下降(开始-6.9 [9
  • 不良事件发生率:低血压DEX-KET 3% [95%CI: 0, 9],DEX 7% [95%CI: 2, 14],KET 0% [95%CI: 0, 2];心动过缓DEX-KET 2% [95%CI: 0, 6],DEX 12% [95%CI: 5, 20];氧饱和度下降DEX-KET 3% [95%CI: 0, 8],DEX 2% [95%CI: 0, 6],KET 12% [95%CI: 5, 20],PROP-KET 13% [

证据类型、等级与局限

  • 证据类型:Meta分析(基于15项研究)。
  • 局限:原文未提及具体证据等级或推荐强度;未说明纳入研究的设计类型、偏倚风险或异质性。

对床旁实践的改变

  • 对于需要程序性镇静或术前用药的儿科患者,DEX-KET可能比单用DEX或KET起效更快、苏醒更短,且血流动力学和呼吸更稳定。
  • 单用DEX时需注意心动过缓风险(发生率12%),单用KET或PROP-KET时需注意氧饱和度下降风险(发生率12%和13%)。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate effectiveness of combinational use of dexmedetomidine and ketamine (DEX-KET) for pediatric procedural sedation or premedication.

METHODS: Relevant studies were identified after a literature search in electronic databases and study selection was based on precise eligibility criteria. Meta-analyses of mean differences were performed to examine differences in sedation onset and recovery times between DEX-KET and comparators. Changes from baseline in heart rate (HR), respiratory rate, oxygen saturation, and mean arterial pressure (MAP), were pooled. Meta-analyses of proportions were performed to estimate incidence of adverse events.

RESULTS: 15 studies (1087 patients) were included. Onset of sedation was significantly shorter in DEX-KET than in DEX group. HR declined in DEX-KET group from start (-3.5 beats per minute (BPM) [95% CI: -5.1, -1.9]) through midpoint (-7.2 BPM [95% CI: -12.1, -2.3]) and at end of sedation (-8.7 BPM [95% CI: -13.1, -4.4]). Decrease in HR after DEX administration at start was -11.6 BPM [95% CI: -16.0, -7.1] and remained consistent afterward. There was no change in MAP during DEX-KET sedation. However, after DEX administration, MAP decreased by -6.9 [95% CI: -10.4, -3.3] at start, -7.8 [95% CI: -11.4, -4.2] at middle, and by -6.6 [95% CI: -14.4, 1.1] at end of sedation. Incidence of hypotension was 3% [95% CI: 0, 9] in DEX-KET, 7% [95% CI: 2, 14] in DEX, and 0% [95% CI: 0, 2] in KET groups. Incidence of bradycardia was 2% [95% CI: 0, 6] with DEX-KET and 12% [95% CI: 5, 20] with DEX. Incidence of oxygen desaturation was 3% [95% CI: 0, 8] in DEX-KET, 2% [95% CI: 0, 6] in DEX, 12% [95% CI: 5, 20] in KET, and 13% [95% CI: 6, 21] in PROP-KET groups. MIDA-KET sedation had 13% [95% CI: 4, 25] incidence of tachycardia.

CONCLUSIONS: DEX-KET for pediatric sedation results in better sedation outcomes than DEX or KET by shortening onset of sedation and recovery while maintaining hemodynamic and respiratory stability with low incidence of adverse events. DEX sedation was associated with higher incidence of bradycardia. Higher incidence of oxygen desaturation was observed with KET and PROP-KET whereas MIDA-KET was associated with higher incidence of tachycardia.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Li HP, Liu KP, Yao L, et al. Dexmedetomidine in combination with ketamine for pediatric procedural sedation or premedication: A meta-analysis. Am J Emerg Med. 2021. PMID: 34492589. doi:10.1016/j.ajem.2021.08.073

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。